Bio Green Med Solution, Inc. (NASDAQ: BGMS) Stock Competitors & Peer Comparison
See BGMS's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BGMS and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BGMS | $0.90 | +8.43% | 5M | -0.25 | -$3.56 | N/A |
| RPRX | $66.52 | -0.98% | 29.6B | 12.67 | $5.25 | +1.38% |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| CORT | $80.46 | -0.81% | 8.7B | 229.89 | $0.35 | N/A |
| KNSA | $90.80 | -1.56% | 7.1B | 69.77 | $1.30 | N/A |
| LQDA | $41.85 | -7.12% | 3.7B | 30.55 | $1.37 | N/A |
| PBH | $49.73 | +1.37% | 2.4B | 11.26 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $13.51 | -3.15% | 811.5M | -5.35 | -$2.52 | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
BGMS vs RPRX Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, RPRX has a market cap of 29.6B. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while RPRX trades at $66.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas RPRX's P/E ratio is 12.67. In terms of profitability, BGMS's ROE is -0.32%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, BGMS is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check RPRX's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
BGMS vs WBA Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas WBA's P/E ratio is -1.64. In terms of profitability, BGMS's ROE is -0.32%, compared to WBA's ROE of -0.57%. Regarding short-term risk, BGMS is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check WBA's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
BGMS vs CORT Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CORT has a market cap of 8.7B. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while CORT trades at $80.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas CORT's P/E ratio is 229.89. In terms of profitability, BGMS's ROE is -0.32%, compared to CORT's ROE of +0.08%. Regarding short-term risk, BGMS is less volatile compared to CORT. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check CORT's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
BGMS vs KNSA Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, KNSA has a market cap of 7.1B. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while KNSA trades at $90.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas KNSA's P/E ratio is 69.77. In terms of profitability, BGMS's ROE is -0.32%, compared to KNSA's ROE of +0.17%. Regarding short-term risk, BGMS is less volatile compared to KNSA. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check KNSA's competition here
Liquidia Corporation (NASDAQ: LQDA)
BGMS vs LQDA Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, LQDA has a market cap of 3.7B. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while LQDA trades at $41.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas LQDA's P/E ratio is 30.55. In terms of profitability, BGMS's ROE is -0.32%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, BGMS is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check LQDA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
BGMS vs PBH Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, PBH has a market cap of 2.4B. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while PBH trades at $49.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas PBH's P/E ratio is 11.26. In terms of profitability, BGMS's ROE is -0.32%, compared to PBH's ROE of +0.09%. Regarding short-term risk, BGMS is less volatile compared to PBH. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
BGMS vs HROWL Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas HROWL's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, BGMS is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
BGMS vs HROWM Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas HROWM's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, BGMS is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
BGMS vs LTGO Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, LTGO has a market cap of 811.5M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while LTGO trades at $13.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas LTGO's P/E ratio is -5.35. In terms of profitability, BGMS's ROE is -0.32%, compared to LTGO's ROE of N/A. Regarding short-term risk, BGMS is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check LTGO's competition here
Helus Pharma Inc. (NASDAQ: HELP)
BGMS vs HELP Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, HELP has a market cap of 545.5M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while HELP trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas HELP's P/E ratio is -2.11. In terms of profitability, BGMS's ROE is -0.32%, compared to HELP's ROE of -0.71%. Regarding short-term risk, BGMS is less volatile compared to HELP. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
BGMS vs SVA Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas SVA's P/E ratio is -5.68. In terms of profitability, BGMS's ROE is -0.32%, compared to SVA's ROE of -0.01%. Regarding short-term risk, BGMS is more volatile compared to SVA. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
BGMS vs CUVL Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CUVL has a market cap of 249.9M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while CUVL trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas CUVL's P/E ratio is 10.68. In terms of profitability, BGMS's ROE is -0.32%, compared to CUVL's ROE of N/A. Regarding short-term risk, BGMS is less volatile compared to CUVL. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check CUVL's competition here
High Tide Inc. (NASDAQ: HITI)
BGMS vs HITI Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, HITI has a market cap of 230.9M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while HITI trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas HITI's P/E ratio is -9.57. In terms of profitability, BGMS's ROE is -0.32%, compared to HITI's ROE of -0.36%. Regarding short-term risk, BGMS is less volatile compared to HITI. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check HITI's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
BGMS vs CELG-RI Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CELG-RI has a market cap of 194.1M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while CELG-RI trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to CELG-RI's ROE of +0.44%. Regarding short-term risk, BGMS is more volatile compared to CELG-RI. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check CELG-RI's competition here
Electra Therapeutics Inc. (NASDAQ: ETRA)
BGMS vs ETRA Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, ETRA has a market cap of 155.1M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while ETRA trades at $7.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas ETRA's P/E ratio is -2.76. In terms of profitability, BGMS's ROE is -0.32%, compared to ETRA's ROE of N/A. Regarding short-term risk, BGMS is less volatile compared to ETRA. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check ETRA's competition here
TRex Bio Inc. (NASDAQ: TRXB)
BGMS vs TRXB Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, TRXB has a market cap of 114.4M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while TRXB trades at $13.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas TRXB's P/E ratio is -5.56. In terms of profitability, BGMS's ROE is -0.32%, compared to TRXB's ROE of N/A. Regarding short-term risk, BGMS is less volatile compared to TRXB. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check TRXB's competition here
Atlantic International Corp. (NASDAQ: ATLN)
BGMS vs ATLN Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, ATLN has a market cap of 68.6M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas ATLN's P/E ratio is -0.68. In terms of profitability, BGMS's ROE is -0.32%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, BGMS is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check ATLN's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
BGMS vs CTOR Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CTOR has a market cap of 55.2M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while CTOR trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas CTOR's P/E ratio is -1.26. In terms of profitability, BGMS's ROE is -0.32%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, BGMS is less volatile compared to CTOR. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check CTOR's competition here
Retension Pharmaceuticals Inc. (NASDAQ: RTSN)
BGMS vs RTSN Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, RTSN has a market cap of 43.6M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while RTSN trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas RTSN's P/E ratio is -4.45. In terms of profitability, BGMS's ROE is -0.32%, compared to RTSN's ROE of N/A. Regarding short-term risk, BGMS is less volatile compared to RTSN. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check RTSN's competition here
Rite Aid Corporation (NYSE: RAD)
BGMS vs RAD Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas RAD's P/E ratio is -0.05. In terms of profitability, BGMS's ROE is -0.32%, compared to RAD's ROE of +2.76%. Regarding short-term risk, BGMS is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check RAD's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
BGMS vs GLTO Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas GLTO's P/E ratio is -1.78. In terms of profitability, BGMS's ROE is -0.32%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, BGMS is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check GLTO's competition here
Cosmos Health Inc. (NASDAQ: COSM)
BGMS vs COSM Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, COSM has a market cap of 31.1M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while COSM trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas COSM's P/E ratio is -0.42. In terms of profitability, BGMS's ROE is -0.32%, compared to COSM's ROE of -1.19%. Regarding short-term risk, BGMS is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check COSM's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
BGMS vs NSRX Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, NSRX has a market cap of 27.6M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while NSRX trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas NSRX's P/E ratio is -4.44. In terms of profitability, BGMS's ROE is -0.32%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, BGMS is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check NSRX's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
BGMS vs SCYX Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, SCYX has a market cap of 24M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while SCYX trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas SCYX's P/E ratio is -1.11. In terms of profitability, BGMS's ROE is -0.32%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, BGMS is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check SCYX's competition here
Pomdoctor Limited (NASDAQ: POM)
BGMS vs POM Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, POM has a market cap of 16.4M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while POM trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas POM's P/E ratio is -0.28. In terms of profitability, BGMS's ROE is -0.32%, compared to POM's ROE of +0.80%. Regarding short-term risk, BGMS is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check POM's competition here
Biofrontera Inc. (NASDAQ: BFRI)
BGMS vs BFRI Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, BFRI has a market cap of 13M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while BFRI trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas BFRI's P/E ratio is -1.59. In terms of profitability, BGMS's ROE is -0.32%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, BGMS is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check BFRI's competition here
Cerenome, Inc. (NASDAQ: CNSY)
BGMS vs CNSY Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CNSY has a market cap of 12.9M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while CNSY trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas CNSY's P/E ratio is -0.41. In terms of profitability, BGMS's ROE is -0.32%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, BGMS is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check CNSY's competition here
Azora Therapeutics, Inc. (NASDAQ: AZR)
BGMS vs AZR Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, AZR has a market cap of 10.4M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while AZR trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas AZR's P/E ratio is -0.24. In terms of profitability, BGMS's ROE is -0.32%, compared to AZR's ROE of N/A. Regarding short-term risk, BGMS is less volatile compared to AZR. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check AZR's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
BGMS vs CJJD Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas CJJD's P/E ratio is -0.46. In terms of profitability, BGMS's ROE is -0.32%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, BGMS is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
BGMS vs SSY Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas SSY's P/E ratio is -2.86. In terms of profitability, BGMS's ROE is -0.32%, compared to SSY's ROE of -0.09%. Regarding short-term risk, BGMS is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check SSY's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
BGMS vs SCNX Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, SCNX has a market cap of 5.3M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while SCNX trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas SCNX's P/E ratio is -1.54. In terms of profitability, BGMS's ROE is -0.32%, compared to SCNX's ROE of -0.54%. Regarding short-term risk, BGMS is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check SCNX's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
BGMS vs MDVL Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas MDVL's P/E ratio is -0.05. In terms of profitability, BGMS's ROE is -0.32%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, BGMS is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check MDVL's competition here
Eocene Ltd. (NASDAQ: EOCN)
BGMS vs EOCN Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, EOCN has a market cap of 2.8M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while EOCN trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas EOCN's P/E ratio is -0.19. In terms of profitability, BGMS's ROE is -0.32%, compared to EOCN's ROE of N/A. Regarding short-term risk, BGMS is less volatile compared to EOCN. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check EOCN's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
BGMS vs PAVS Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, PAVS has a market cap of 2.7M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while PAVS trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas PAVS's P/E ratio is -0.03. In terms of profitability, BGMS's ROE is -0.32%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, BGMS is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check PAVS's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
BGMS vs ATNFW Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas ATNFW's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, BGMS is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
BGMS vs BGMSP Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, BGMS's ROE is -0.32%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, BGMS is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
BGMS vs AZNH Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas AZNH's P/E ratio is 38.35. In terms of profitability, BGMS's ROE is -0.32%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, BGMS is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check AZNH's competition here
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP)
BGMS vs ASBP Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, ASBP has a market cap of 842.2K. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while ASBP trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas ASBP's P/E ratio is -0.31. In terms of profitability, BGMS's ROE is -0.32%, compared to ASBP's ROE of +19.93%. Regarding short-term risk, BGMS is less volatile compared to ASBP. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check ASBP's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
BGMS vs BFRIW Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, BFRIW has a market cap of 796.7K. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while BFRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas BFRIW's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, BGMS is more volatile compared to BFRIW. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check BFRIW's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
BGMS vs LFLYW Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, BGMS's ROE is -0.32%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, BGMS is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check LFLYW's competition here
Aspire Biopharma Holdings, Inc. (NASDAQ: ASBPW)
BGMS vs ASBPW Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, ASBPW has a market cap of 149.5K. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while ASBPW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas ASBPW's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to ASBPW's ROE of +19.93%. Regarding short-term risk, BGMS is less volatile compared to ASBPW. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check ASBPW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
BGMS vs PRPH Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, PRPH has a market cap of 91.1K. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while PRPH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas PRPH's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, BGMS is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check PRPH's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
BGMS vs OREX Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, OREX has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas OREX's P/E ratio is -0.14. In terms of profitability, BGMS's ROE is -0.32%, compared to OREX's ROE of -0.54%. Regarding short-term risk, BGMS is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check OREX's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
BGMS vs CPD Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, CPD has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas CPD's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to CPD's ROE of N/A. Regarding short-term risk, BGMS is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check CPD's competition here
POZEN Inc. (NASDAQ: POZN)
BGMS vs POZN Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, POZN has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas POZN's P/E ratio is N/A. In terms of profitability, BGMS's ROE is -0.32%, compared to POZN's ROE of +0.61%. Regarding short-term risk, BGMS is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check POZN's competition here
Shire plc (NASDAQ: SHPG)
BGMS vs SHPG Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while SHPG trades at $179.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas SHPG's P/E ratio is 11.35. In terms of profitability, BGMS's ROE is -0.32%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, BGMS is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check SHPG's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
BGMS vs ESRX Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas ESRX's P/E ratio is 10.69. In terms of profitability, BGMS's ROE is -0.32%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, BGMS is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for BGMS.Check ESRX's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
BGMS vs IPXL Comparison November 2026
Bio Green Med Solution, Inc. (NASDAQ: BGMS) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGMS stands at 5M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, BGMS is priced at $0.90 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGMS currently has a P/E ratio of -0.25, whereas IPXL's P/E ratio is -10.11. In terms of profitability, BGMS's ROE is -0.32%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, BGMS is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for BGMS.Check IPXL's competition here